6α-Methylprednisolone
SIGMA/M0639 - ≥98%
Synonym: 11β,17α,21-Trihydroxy-6α-methyl-1,4-pregnadiene-3,20-dione; 6α-Methyl-11β,17α,21-trihydroxy-1,4-pregnadiene-3,20-dione; Medrol; Medrone
CAS Number: 83-43-2
Empirical Formula (Hill Notation): C22H30O5
Molecular Weight: 374.47
EC Number: 201-476-4
MDL Number: MFCD00010591
Linear Formula: C22H30O5
Product Type: Chemical
| application(s) | cell analysis |
| assay | ≥98% |
| biological source | synthetic |
| form | powder |
| InChI | 1S/C22H30O5/c1-12-8-14-15 |
| InChI key | VHRSUDSXCMQTMA-PJHHCJLFSA |
| Quality Level | 200 ![]() |
| shipped in | ambient |
| SMILES string | [H][C@@]12C[C@H](C)C3=CC( |
| solubility | chloroform: methanol (1:1): 50 mg/mL, clear, colorless to faintly yellow |
| sterility | non-sterile |
| storage temp. | room temp |
| Application: | 6α-Methylprednisolone has been used: • to stimulate RPMI 8226.1 cells in order to govern the expression of human interleukin-10 (IL-10) gene • to induce depletion of CD14+ CD16+ monocytes • to study its effect on behavioral and sensory afferent hypersensitivity |
| Biochem/physiol Actions: | Methylprednisolone is a glucocorticoid having anti-inflammatory and immunosuppressive actions. It is useful in treating skin diseases, allergies, multiple sclerosis, asthma, rheumatic disorders, chronic obstructive pulmonary disease, croup and cancer. |
| Packaging: | Bottomless glass bottle. Contents are inside inserted fused cone. |
| Symbol | GHS08 |
| Signal word | Danger |
| Hazard statements | H360D - H373 |
| Precautionary statements | P201 - P308 + P313 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 2 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |


